M. L. Stracke, H. C. Krutzsch, E. J. Unsworth, A. Arestad, V. Cioce et al., Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein, J. Biol. Chem, vol.267, pp.2524-2529, 1992.

S. W. Nam, T. Clair, C. K. Campo, H. Y. Lee, L. A. Liotta et al., Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells, Oncogene, vol.19, pp.241-247, 2000.

M. Umezu-goto, Y. Kishi, A. Taira, K. Hama, N. Dohmae et al., Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production, J. Cell Biol, vol.158, pp.227-233, 2002.

A. Tokumura, E. Majima, Y. Kariya, K. Tominaga, K. Kogure et al., Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase, J. Biol. Chem, vol.277, pp.39436-39442, 2002.

J. Aoki, A. Taira, Y. Takanezawa, Y. Kishi, K. Hama et al., Serum lysophosphatidic acid is produced through diverse phospholipase pathways, J. Biol. Chem, vol.277, pp.48737-48744, 2002.

N. Fukushima, Y. Kimura, and J. Chun, A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid, Proc. Natl. Acad. Sci, vol.95, pp.6151-6156, 1998.

C. W. Lee, R. Rivera, S. Gardell, A. E. Dubin, and J. Chun, GPR92 as a new G12/13-and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5, J. Biol. Chem, vol.281, pp.23589-23597, 2006.

I. Ishii, J. J. Contos, N. Fukushima, and J. Chun, Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system, Mol. Pharmacol, vol.58, pp.895-902, 2000.

K. Bandoh, J. Aoki, A. Taira, M. Tsujimoto, H. Arai et al., Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors, FEBS Lett, vol.478, pp.159-165, 2000.

K. Yanagida, K. Masago, H. Nakanishi, Y. Kihara, F. Hamano et al., Identification and Characterization of a Novel Lysophosphatidic Acid Receptor, p2y5/LPA6, J. Biol. Chem, vol.284, pp.17731-17741, 2009.

C. W. Lee, R. Rivera, A. E. Dubin, and J. Chun, LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation, J. Biol. Chem, vol.282, pp.4310-4317, 2007.

A. Kehlen, N. Englert, A. Seifert, T. Klonisch, H. Dralle et al., Expression, regulation and function of autotaxin in thyroid carcinomas, Int. J. Cancer, vol.109, pp.833-838, 2004.

A. Kehlen, R. Lauterbach, A. N. Santos, K. Thiele, U. Kabisch et al., IL-1 betaand IL-4-induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA), Clin. Exp. Immunol, vol.123, pp.147-154, 2001.

C. Kime, M. Sakaki-yumoto, L. Goodrich, Y. Hayashi, S. Sami et al., Autotaxin-mediated lipid signaling intersects with LIF and BMP signaling to promote the naive pluripotency transcription factor program, Proc. Natl. Acad. Sci, vol.113, pp.12478-12483, 2016.

S. Flammier, O. Peyruchaud, F. Bourguillault, F. Duboeuf, J. L. Davignon et al., Osteoclast-Derived Autotaxin, a Distinguishing Factor for Inflammatory Bone Loss, Arthritis Rheumatol, vol.71, pp.1801-1811, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02354473

J. M. Wu, Y. Xu, N. J. Skill, H. Sheng, Z. Zhao et al., Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma, Mol. Cancer, vol.9, p.71, 2010.

B. Zirn, B. Samans, S. Wittmann, T. Pietsch, I. Leuschner et al., Target genes of the WNT/beta-catenin pathway in Wilms tumors, Genes Chromosomes Cancer, vol.45, pp.565-574, 2006.

M. Chen and K. L. O'connor, Integrin alpha6beta4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells, Oncogene, vol.24, pp.5125-5130, 2005.

N. Leclerc, C. A. Luppen, V. V. Ho, S. Nagpal, J. G. Hacia et al., Gene expression profiling of glucocorticoid-inhibited osteoblasts, J. Mol. Endocrinol, vol.33, pp.175-193, 2004.

J. Dufner-beattie, R. S. Lemons, and A. Thorburn, Retinoic acid-induced expression of autotaxin in N-myc-amplified neuroblastoma cells, Mol. Carcinog, vol.30, pp.181-189, 2001.

E. J. Black, T. Clair, J. Delrow, P. Neiman, and D. A. Gillespie, Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun, Oncogene, vol.23, pp.2357-2366, 2004.

J. P. Pradere, E. Tarnus, S. Gres, P. Valet, and J. S. Saulnier-blache, Secretion and lysophospholipase D activity of autotaxin by adipocytes are controlled by N-glycosylation and signal peptidase, Biochim. Biophys. Acta, vol.1771, pp.93-102, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00115644

S. Jansen, M. Andries, K. Vekemans, H. Vanbilloen, A. Verbruggen et al., Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells, Cancer Lett, vol.284, pp.216-221, 2009.

A. J. Morris, S. Selim, A. Salous, and S. S. Smyth, Blood Relatives: Dynamic Regulation of Bioactive Lysophosphatidic acid and Sphingosine-1-Phosphate Metabolism in the Circulation, Trends Cardiovasc. Med, vol.19, pp.135-140, 2009.

G. Tigyi and R. Miledi, Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells, J. Biol. Chem, vol.267, pp.21360-21367, 1992.

S. Liu, M. Umezu-goto, M. Murph, Y. Lu, W. Liu et al., Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases, Cancer Cell, vol.15, pp.539-550, 2009.

A. Masuda, K. Nakamura, K. Izutsu, K. Igarashi, R. Ohkawa et al., Serum autotaxin measurement in haematological malignancies: A promising marker for follicular lymphoma, Br. J. Haematol, vol.143, pp.60-70, 2008.

Y. Nakai, H. Ikeda, K. Nakamura, Y. Kume, M. Fujishiro et al., Specific increase in serum autotaxin activity in patients with pancreatic cancer, Clin. Biochem, vol.44, pp.576-581, 2011.

G. Zhang, Z. Zhao, S. Xu, L. Ni, and X. Wang, Expression of autotaxin mRNA in human hepatocellular carcinoma, Chin. Med. J, vol.112, pp.330-332, 1999.

G. J. Tigyi, J. Yue, D. D. Norman, E. Szabo, A. Balogh et al., Regulation of tumor cell-Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis, Adv. Biol. Regul, vol.71, pp.183-193, 2019.

A. Boucharaba, C. Serre, S. Gres, J. S. Saulnier-blache, J. Bordet et al., Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer, J. Clin. Investig, vol.114, pp.1714-1725, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-00110127

R. Leblanc, S. C. Lee, M. David, J. C. Bordet, D. D. Norman et al., Interaction of platelet-derived autotaxin with tumor integrin alphaVbeta3 controls metastasis of breast cancer cells to bone, Blood, vol.124, pp.3141-3150, 2014.

M. G. Benesch, Y. M. Ko, X. Tang, J. Dewald, A. Lopez-campistrous et al., Autotaxin is an inflammatory mediator and therapeutic target in thyroid cancer, Endocr.-Relat. Cancer, vol.22, pp.593-607, 2015.

M. G. Benesch, X. Tang, J. Dewald, W. F. Dong, J. R. Mackey et al., Tumor-induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression, FASEB J, vol.29, pp.3990-4000, 2015.

R. Leblanc and O. Peyruchaud, New insights into the autotaxin/LPA axis in cancer development and metastasis, Exp. Cell Res, vol.333, pp.183-189, 2015.

M. G. Benesch, Z. Yang, X. Tang, G. Meng, D. N. Brindley et al., The Tumor Microenvironment's New Nemesis. Trends Cancer, vol.3, pp.748-752, 2017.

M. G. Benesch, I. T. Macintyre, T. P. Mcmullen, and D. N. Brindley, Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation, Cancers, vol.10, 2018.

M. David, E. Wannecq, F. Descotes, S. Jansen, B. Deux et al., Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts, PLoS ONE, vol.5, 2010.

S. Vidot, J. Witham, R. Agarwal, S. Greenhough, H. S. Bamrah et al., Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells, Cell. Signal, vol.22, pp.926-935, 2010.

A. Mazzocca, L. M. Schönauer, R. De-nola, A. Lippolis, T. Marrano et al., Autotaxin is a novel molecular identifier of type I endometrial cancer, Med. Oncol, vol.35, 2018.

Y. Shao, Y. Yu, Y. He, Q. Chen, and H. Liu, Serum ATX as a novel biomarker for breast cancer, Medicine, vol.98, 2019.

C. Magkrioti, N. Oikonomou, E. Kaffe, M. A. Mouratis, N. Xylourgidis et al., The autotaxin-Lysophosphatidic acid axis promotes lung carcinogenesis, Cancer Res, vol.78, pp.3634-3644, 2018.

L. A. Van-meeteren, P. Ruurs, E. Christodoulou, J. W. Goding, H. Takakusa et al., Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate, J. Biol. Chem, vol.280, pp.21155-21161, 2005.

G. Ferry, N. Moulharat, J. P. Pradere, P. Desos, A. Try et al., S32826: A nanomolar inhibitor of autotaxin. Discovery, synthesis and applications as a pharmacological tool, J. Pharmacol. Exp. Ther, vol.327, pp.809-819, 2008.

R. Gupte, R. Patil, J. Liu, Y. Wang, S. C. Lee et al., Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity, ChemMedChem, vol.6, pp.922-935, 2011.

M. Gotoh, Y. Fujiwara, J. Yue, J. Liu, S. Lee et al., Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis, Biochem. Soc. Trans, vol.40, pp.31-36, 2012.

J. Gierse, A. Thorarensen, K. Beltey, E. Bradshaw-pierce, L. Cortes-burgos et al., A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation, J. Pharmacol. Exp. Ther, vol.334, pp.310-317, 2010.

H. Saga, A. Ohhata, A. Hayashi, M. Katoh, T. Maeda et al., A Novel Highly Potent Autotaxin/ENPP2 Inhibitor Produces Prolonged Decreases in Plasma Lysophosphatidic Acid Formation in Vivo and Regulates Urethral Tension, PLoS ONE, vol.9, 2014.

S. R. Bhave, D. Y. Dadey, R. M. Karvas, D. J. Ferraro, R. P. Kotipatruni et al., Autotaxin Inhibition with PF-8380 Enhances the Radiosensitivity of Human and Murine Glioblastoma Cell Lines

M. G. Benesch, X. Tang, T. Maeda, A. Ohhata, Y. Y. Zhao et al., Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice, FASEB J, vol.28, pp.2655-2666, 2014.

T. M. Maher, M. Kreuter, D. J. Lederer, K. K. Brown, W. Wuyts et al., Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2), BMJ Open Respir. Res, vol.6, 2019.

X. Tang, M. Wuest, M. G. Benesch, J. Dufour, Y. Zhao et al., Inhibition of autotaxin with GLPG1690 increases the efficacy of radiotherapy and chemotherapy in a mouse model of breast cancer, Mol. Cancer Ther, 2019.

H. Zhang, X. Xu, J. Gajewiak, R. Tsukahara, Y. Fujiwara et al., Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo, Cancer Res, vol.69, pp.5441-5449, 2009.

S. M. Schleicher, D. K. Thotala, A. G. Linkous, R. Hu, K. M. Leahy et al., Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature, PLoS ONE, vol.6, 2011.

P. Iyer, R. Lalane, C. Morris, P. Challa, R. Vann et al., Autotaxin-lysophosphatidic acid axis is a novel molecular target for lowering intraocular pressure, PLoS ONE, vol.7, 2012.

N. Oikonomou, M. A. Mouratis, A. Tzouvelekis, E. Kaffe, C. Valavanis et al., Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis, Am. J. Respir. Cell Mol. Biol, vol.47, pp.566-574, 2012.

S. H. Hwang, B. H. Lee, H. J. Kim, H. J. Cho, H. C. Shin et al., Suppression of metastasis of intravenously-inoculated B16/F10 melanoma cells by the novel ginseng-derived ingredient, gintonin: Involvement of autotaxin inhibition, Int. J. Oncol, vol.42, pp.317-326, 2013.

O. Peyruchaud, M. David, T. L. Macdonald, and K. R. Lynch, Lysophosphatidic Acid (LPA) Signaling in Bone Cancer, Lysophospholipid Receptors

J. Chun, T. Hla, and W. Moolenaar, , pp.627-640, 2013.

X. Tang, M. G. Benesch, and D. N. Brindley, Lipid phosphate phosphatases and their roles in mammalian physiology and pathology, J. Lipid Res, vol.56, pp.2048-2060, 2015.

J. Hausmann, S. Kamtekar, E. Christodoulou, J. E. Day, T. Wu et al., Structural basis of substrate discrimination and integrin binding by autotaxin, Nat. Struct. Mol. Biol, vol.18, pp.198-204, 2011.

H. Kanda, R. Newton, R. Klein, Y. Morita, M. D. Gunn et al., Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs, Nat. Immunol, vol.9, pp.415-423, 2008.

Z. Pamuklar, L. Federico, S. Liu, M. Umezu-goto, A. Dong et al., Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis, J. Biol. Chem, vol.284, pp.7385-7394, 2009.

T. Wu, C. V. Kooi, P. Shah, R. Charnigo, C. Huang et al., Integrin-mediated cell surface recruitment of autotaxin promotes persistent directional cell migration, FASEB J, vol.28, pp.861-870, 2014.

H. Nishimasu, S. Okudaira, K. Hama, E. Mihara, N. Dohmae et al., Crystal structure of autotaxin and insight into GPCR activation by lipid mediators, Nat. Struct. Mol. Biol, vol.18, pp.205-212, 2011.

Z. Fulkerson, T. Wu, M. Sunkara, C. V. Kooi, A. J. Morris et al., Binding of autotaxin to integrins localizes lysophosphatidic acid production to platelets and mammalian cells, J. Biol. Chem, vol.286, pp.34654-34663, 2011.

A. J. Houben, X. M. Van-wijk, L. A. Van-meeteren, L. Van-zeijl, E. M. Van-de-westerlo et al., The polybasic insertion in autotaxin alpha confers specific binding to heparin and cell surface heparan sulfate proteoglycans, J. Biol. Chem, vol.288, pp.510-519, 2013.

R. Leblanc, D. Sahay, A. Houssin, I. Machuca-gayet, and O. Peyruchaud, Autotaxin-beta interaction with the cell surface via syndecan-4 impacts on cancer cell proliferation and metastasis, Oncotarget, vol.9, pp.33170-33185, 2018.

S. A. Jethwa, E. J. Leah, Q. Zhang, N. A. Bright, D. Oxley et al., Exosomes bind to autotaxin and act as a physiological delivery mechanism to stimulate LPA receptor signalling in cells, J. Cell Sci, vol.129, pp.3948-3957, 2016.

G. Cohen, L. Gossec, M. Dougados, A. Cantagrel, P. Goupille et al., Radiological damage in patients with rheumatoid arthritis on sustained remission, Ann. Rheum. Dis, vol.66, pp.358-363, 2007.

K. Redlich, S. Hayer, R. Ricci, J. David, M. Tohidast-akrad et al., Osteoclasts are essential for TNF-{alpha}-mediated joint destruction, J. Clin. Investig, vol.110, pp.1419-1427, 2002.

E. T. Molenaar, A. E. Voskuyl, H. J. Dinant, P. D. Bezemer, M. Boers et al., Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission, Arthritis Rheum, vol.50, pp.36-42, 2004.

A. K. Brown, P. G. Conaghan, Z. Karim, M. A. Quinn, K. Ikeda et al., An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis, Arthritis Rheum, vol.58, pp.2958-2967, 2008.

Y. Miyabe, C. Miyabe, Y. Iwai, A. Takayasu, S. Fukuda et al., Necessity of lysophosphatidic acid receptor 1 for development of arthritis, Arthritis Rheum, vol.65, pp.2037-2047, 2013.

C. Zhao, M. J. Fernandes, G. D. Prestwich, M. Turgeon, J. Di-battista et al., Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: Implications for rheumatoid arthritis?, Mol. Pharmacol, vol.73, pp.587-600, 2008.

I. Nikitopoulou, N. Oikonomou, E. Karouzakis, I. Sevastou, N. Nikolaidou-katsaridou et al., Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis, J. Exp. Med, vol.209, pp.925-933, 2012.

M. David, I. Machuca-gayet, J. Kikuta, P. Ottewell, F. Mima et al., Lysophosphatidic Acid Receptor Type 1 (LPA1) Plays a Functional Role in Osteoclast Differentiation and Bone Resorption Activity, J. Biol. Chem, vol.289, pp.6551-6564, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02353369

R. Dusaulcy, D. Daviaud, J. P. Pradere, S. Gres, P. Valet et al., Altered food consumption in mice lacking lysophosphatidic acid receptor-1, J. Physiol. Biochem, vol.65, pp.345-350, 2009.

J. J. Contos, N. Fukushima, J. A. Weiner, D. Kaushal, and J. Chun, Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior, Proc. Natl. Acad. Sci, vol.97, pp.13384-13389, 2000.

X. Ye, K. Hama, J. J. Contos, B. Anliker, A. Inoue et al., LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing, Nature, vol.435, pp.104-108, 2005.

T. Nishioka, N. Arima, K. Kano, K. Hama, E. Itai et al., ATX-LPA1 axis contributes to proliferation of chondrocytes by regulating fibronectin assembly leading to proper cartilage formation

N. Panupinthu, J. T. Rogers, L. Zhao, L. P. Solano-flores, F. Possmayer et al., P2 × 7 receptors on osteoblasts couple to production of lysophosphatidic acid: A signaling axis promoting osteogenesis, J. Cell Biol, vol.181, pp.859-871, 2008.

G. Ferry, E. Tellier, A. Try, S. Gres, I. Naime et al., Autotaxin Is Released from Adipocytes, Catalyzes Lysophosphatidic Acid Synthesis, and Activates Preadipocyte Proliferation. Up-Regulated Expression with Adipocyte Differentiation and Obesity, J. Biol. Chem, vol.278, pp.18162-18169, 2003.
URL : https://hal.archives-ouvertes.fr/inserm-00110135

K. N. Weilbaecher, T. A. Guise, and L. K. Mccauley, Cancer to bone: A fatal attraction, Nat. Rev. Cancer, vol.11, pp.411-425, 2011.

D. J. Heath, K. Vanderkerken, X. Cheng, O. Gallagher, M. Prideaux et al., An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma, Cancer Res, vol.67, pp.202-208, 2007.

F. R. Greten and S. I. Grivennikov, Inflammation and Cancer: Triggers, Mechanisms, and Consequences, Immunity, vol.51, pp.27-41, 2019.

K. P. Mchugh, K. Hodivala-dilke, M. H. Zheng, N. Namba, J. Lam et al., Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts, J. Clin. Investig, vol.105, pp.433-440, 2000.